Norway
· Delayed Price · Currency is NOK Aqua Bio Technology ASA Statistics
Total Valuation
Aqua Bio Technology ASA has a market cap or net worth of NOK 363.53 million. The enterprise value is 442.07 million.
| Market Cap | 363.53M |
| Enterprise Value | 442.07M |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Aqua Bio Technology ASA has 108.84 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 108.84M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +73.19% |
| Owned by Insiders (%) | 5.52% |
| Owned by Institutions (%) | n/a |
| Float | 85.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.00 |
| PB Ratio | 8.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -294.16 |
| EV / Sales | 31.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.33, with a Debt / Equity ratio of 3.06.
| Current Ratio | 0.33 |
| Quick Ratio | 0.09 |
| Debt / Equity | 3.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.49 |
Financial Efficiency
Return on equity (ROE) is -19.67% and return on invested capital (ROIC) is -34.07%.
| Return on Equity (ROE) | -19.67% |
| Return on Assets (ROA) | -17.96% |
| Return on Capital (ROIC) | -34.07% |
| Revenue Per Employee | 3.45M |
| Profits Per Employee | -375,701 |
| Employee Count | 4 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 0.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.43% in the last 52 weeks. The beta is 0.71, so Aqua Bio Technology ASA's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -36.43% |
| 50-Day Moving Average | 2.21 |
| 200-Day Moving Average | 3.36 |
| Relative Strength Index (RSI) | 71.00 |
| Average Volume (20 Days) | 294,603 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aqua Bio Technology ASA had revenue of NOK 13.82 million and -1.50 million in losses. Loss per share was -0.09.
| Revenue | 13.82M |
| Gross Profit | 9.32M |
| Operating Income | -12.61M |
| Pretax Income | -1.46M |
| Net Income | -1.50M |
| EBITDA | -11.11M |
| EBIT | -12.61M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 727,437 in cash and 23.51 million in debt, giving a net cash position of -22.79 million or -0.21 per share.
| Cash & Cash Equivalents | 727,437 |
| Total Debt | 23.51M |
| Net Cash | -22.79M |
| Net Cash Per Share | -0.21 |
| Equity (Book Value) | 7.68M |
| Book Value Per Share | 0.37 |
| Working Capital | -22.49M |
Cash Flow
| Operating Cash Flow | -9.71M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 67.43%, with operating and profit margins of -91.23% and -10.88%.
| Gross Margin | 67.43% |
| Operating Margin | -91.23% |
| Pretax Margin | -10.60% |
| Profit Margin | -10.88% |
| EBITDA Margin | -80.42% |
| EBIT Margin | -91.23% |
| FCF Margin | n/a |
Dividends & Yields
Aqua Bio Technology ASA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.21% |
| Shareholder Yield | -3.21% |
| Earnings Yield | -2.80% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 27, 2011. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 27, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
Aqua Bio Technology ASA has an Altman Z-Score of -0.4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.4 |
| Piotroski F-Score | n/a |